🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alexandre V. Hirayama

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0001-7980-3882

Also affiliated with University of Washington, Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 13 papers. Top paper: “Toxicities of CD19 CAR‐T cell immunotherapy”.

Toxicities of CD19 CAR‐T cell immunotherapy

American Journal of Hematology(2019)10.1002/ajh.25445
N/A
6.3DataRank · unranked
139 citations

Cameron J. Turtle, Alexandre V. Hirayama

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023011287
N/A
1.7DataRank · unranked
55 citations

Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna Voutsinas +18 more

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Blood Advances(2023)10.1182/bloodadvances.2023011399
N/A
0.958DataRank · unranked
34 citations

Aya Albittar, Jennifer J. Huang, Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese +11 more

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL

Blood Advances(2025)10.1182/bloodadvances.2024015314
N/A
0.447DataRank · unranked
10 citations

Emily C. Liang, Jennifer J. Huang, Erik L. Kimble, Alexandre V. Hirayama, Salvatore Fiorenza +15 more

Development and validation of predictive models of early immune effector cell–associated hematotoxicity

Blood Advances(2024)10.1182/bloodadvances.2024014455
N/A
0.360DataRank · unranked
10 citations

Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz‐Maldonado, Aya Albittar, Natalie Wuliji +28 more

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Blood(2022)10.1182/blood.2021014497
N/A
0DataRank · unranked
54 citations

Nicolas Gazeau, Alexandre V. Hirayama, Joshua A. Hill, Vicky Wu, Aisling Cearley +17 more

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

Blood(2020)10.1182/blood.2019002936
N/A
0DataRank · unranked
321 citations

Alexandre V. Hirayama, Janaki Purushe, Kevin A. Hay, James Lymp, Daniel H. Li +12 more

Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7511
N/A
0DataRank · unranked
1 citations

Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese, Aya Albittar, Aude G. Chapuis +8 more

qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue

PLoS ONE(2024)10.1371/journal.pone.0303057
N/A
0DataRank · unranked
0 citations

Graeme C. Black, Marie Bleakley, Denise Buenrostro, Aude G. Chapuis, Alexandre V. Hirayama +12 more

Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes

Immunity(2025)10.1016/j.immuni.2025.09.004
N/A
0DataRank · unranked
3 citations

Françoise Haeseleer, Olivia G. Waltner, Kate H. Gartlan, Shruti S. Bhise, Simone A. Minnie +18 more

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

Blood Advances(2022)10.1182/bloodadvances.2022008697
N/A
0DataRank · unranked
26 citations

Cassie Chou, Takahiro Miyazaki, Rachel N. Steinmetz, Henna A Di, Simon P. Fraessle +8 more

Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies

JCI Insight(2021)10.1172/jci.insight.146743
N/A
0DataRank · unranked
62 citations

Elizabeth M. Krantz, Joyce Maalouf, Jim Boonyaratanakornkit, Jacob Keane-Candib, Laurel Joncas-Schronce +13 more

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.04.001
N/A
0DataRank · unranked
140 citations

Emily C. Liang, Qian Wu, Jenna Voutsinas, Pere Barba, Gloria Iacoboni +19 more